3-Methyl-2-oxo-1,2,5,6,7,8-hexahydro-chinolin | 90874-65-0

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 喹啉及其衍生物
• 英文名称: 3-Methyl-2-oxo-1,2,5,6,7,8-hexahydro-chinolin
• 英文别名: 3-methyl-5,6,7,8-tetrahydro-1H-quinolin-2-one；3-methyl-5,6,7,8-tetrahydro-1H-quinolin-2-one
• CAS: 90874-65-0
• 化学式: C₁₀H₁₃NO
• 分子量: 163.219
• InChiKey: KFPHIDPBLUWZHE-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.3
• 重原子数：
  12
• 可旋转键数：
  0
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.5
• 拓扑面积：
  29.1
• 氢给体数：
  1
• 氢受体数：
  1

文献信息

• [EN] ESTRA-1,3,5(10)-TRIENE COMPOUNDS CONDENSED IN POSITION 16(17) WITH A PYRAZOLE RING AS INHIBITORS OF 17-HSD1<br/>[FR] COMPOSÉS ESTRA-1,3,5(10)-TRIÈNE CONDENSÉS EN POSITION 16(17) AVEC UN CYCLE PYRAZOLE UTILISÉS COMME INHIBITEURS DE LA 17-HSD1
  申请人：FORENDO PHARMA LTD

  公开号：WO2020115371A1

  公开（公告）日：2020-06-11

  The invention relates to compounds of formula (I) and pharmaceutically acceptable salts thereof (I) wherein R1 to R4 are as defined in the claims. The invention further relates to their use as inhibitors of 17β-HSD1 and in treatment or prevention of steroid hormone dependent dis-eases or disorders, such as steroid hormone dependent dis-eases or disorders requiring the inhibition of the 17β-HSD1 enzyme and/or requiring the lowering of the endogenous estradiol concentration. The present invention also relates to the preparation of the aforementioned compounds and to pharmaceutical compositions comprising as an active ingredient(s) one or more of the aforementioned compounds or pharmaceutically acceptable salts thereof.

  该发明涉及式（I）的化合物及其药用盐（I），其中R1至R4如权利要求中所定义。该发明还涉及它们作为17β-HSD1的抑制剂的用途，以及用于治疗或预防类固醇激素依赖性疾病或紊乱，如需要抑制17β-HSD1酶和/或需要降低内源性雌二醇浓度的类固醇激素依赖性疾病或紊乱。本发明还涉及上述化合物的制备以及包含上述化合物或其药用盐作为活性成分的药物组合物。
• [EN] COMPOUNDS<br/>[FR] COMPOSÉS
  申请人：PULMOCIDE LTD

  公开号：WO2017175000A1

  公开（公告）日：2017-10-12

  There are provided 5,6-dihydro-4H-dithieno[3,2-b:2',3'-d]azepine derivatives(as defined in the disclosure) which are useful in the treatment of RSV infection and for the prevention of disease associated with RSV infection.

  提供了5,6-二氢-4H-二硫代[3,2-b:2',3'-d]氮杂环庚烷衍生物（如披露中定义的），对RSV感染的治疗和预防与RSV感染相关的疾病具有用处。
• CINNAMOYL COMPOUND AND USE THEREOF
  申请人：Sumitomo Chemical Company, Limited

  公开号：EP1857455A1

  公开（公告）日：2007-11-21

  Disclosed is an extracellular matrix genetranscription inhibitor composition or the like characterized by containing a cinnamoyl compound represented by the formula(I) below: and an inert carrier.

  揭示了一种包含下面式(I)所代表的肉桂酰化合物和惰性载体的细胞外基质基因转录抑制剂组合物或类似物。
• Cinnamoyl Compound and Use Thereof
  申请人：Shiraki Hiroaki

  公开号：US20100081652A1

  公开（公告）日：2010-04-01

  Disclosed is an extracellular matrix genetranscription inhibitor composition or the like characterized by containing a cinnamoyl compound represented by the formula (I) below: and an inert carrier.

  本发明涉及一种细胞外基质基因转录抑制剂组合物，其特征在于包含以下式子（I）所表示的肉桂酰化合物和惰性载体。
• HETEROCYCLIC COMPOUNDS FOR THE TREATMENT OF STRESS-RELATED CONDITIONS
  申请人：Takahashi Akira

  公开号：US20120065189A1

  公开（公告）日：2012-03-15

  The present invention provides a novel heterocyclic compound. A heterocyclic compound represented by general formula (1) wherein, R 1 and R 2 , each independently represent hydrogen; a phenyl lower alkyl group that may have a substituent(s) selected from the group consisting of a lower alkyl group and the like on a benzene ring and/or a lower alkyl group; or a cyclo C3-C8 alkyl lower alkyl group; or the like; R 3 represents a lower alkynyl group or the like; R 4 represents a phenyl group that may have a substituent(s) selected from the group consisting of a 1,3,4-oxadiazolyl group that may have e.g., halogen or a heterocyclic group selected from pyridyl group and the like; the heterocyclic group may have at least one substituent(s) selected from a lower alkoxy group and the like or a salt thereof.

  本发明提供了一种新型杂环化合物。所述杂环化合物的通式（1）表示，其中，R1和R2各自独立地表示氢；苯基低烷基，其可以在苯环上和/或低烷基上具有选自低烷基等的取代基；或环状C3-C8烷基低烷基；或类似物；R3表示低炔基或类似物；R4表示苯基，其可以具有选自1,3,4-噁二唑基（例如，卤素）或选自吡啶基等杂环基的取代基；所述杂环基可以具有至少一个选自低烷氧基等的取代基或其盐。